Needham upgrades Rocket Pharmaceuticals to Buy after FDA alignment

Needham upgraded Rocket Pharmaceuticals (RCKT) to ‘Buy’ from… after the company aligned with the U.S. FDA on a pivotal study for its experimental genetic disease therapy.